Abstract
Cardiovascular disease is an important extra-articular manifestation of rheumatologic diseases leading to considerable mortality and morbidity. Echocardiography emerges as a useful non-invasive technique for the screening and evaluation of cardiac involvement in these patients. With the technological advancement in echocardiographic techniques, we have gained a greater appreciation of the prevalence and nature of the cardiac involvement in these patients, as detection of subclinical disease is increasingly feasible. This review discusses cardiac involvement in patients with rheumatoid arthritis, systemic lupus erythematosus, anti-phospholipid antibody syndrome, systemic sclerosis and ankylosing spondylitis, and the role of different echocardiographic modalities in their evaluation.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Prasad M et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol. 2015;12(3):168–76. A recent review on the cardiovascular manifestations in patients with rheumatic diseases, their underlying pathophysiology and management strategies.
Hollan I et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev. 2013;12(10):1004–15.
Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford). 2006;45 Suppl 4:iv4–7.
Aslam F et al. Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res (Hoboken). 2013;65(4):534–43.
Faccini, A., J.C. Kaski, and P.G. Camici, Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases. Eur Heart J, 2016. This recent paper reviewed coronary microvascular dysfunction (CMD) in chronic inflammatory rheumatoid diseases and the authors proposed a diagnostic algorithm which involves non-invasive imaging for the identification of CMD in these patients.
Wislowska M, Sypula S, Kowalik I. Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker’s criteria, functional index, value of Waaler-Rose titre and duration of disease. Clin Rheumatol. 1998;17(5):369–77.
Roldan CA et al. Characterization of valvular heart disease in rheumatoid arthritis by transesophageal echocardiography and clinical correlates. Am J Cardiol. 2007;100(3):496–502.
Dweik RA et al. An official American Thoracic Society Statement: pulmonary hypertension phenotypes. Am J Respir Crit Care Med. 2014;189(3):345–55.
Wislowska M et al. Systolic and diastolic heart function in SLE patients. Rheumatol Int. 2009;29(12):1469–76.
Miner JJ, Kim AH. Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am. 2014;40(1):51–60.
Leal GN et al. Subclinical right ventricle systolic dysfunction in childhood-onset systemic lupus erythematosus: insights from two-dimensional speckle-tracking echocardiography. Lupus. 2015;24(6):613–20.
Shazzad MN et al. Echocardiographic assessment of cardiac involvement in systemic lupus erythematosus patients. Mymensingh Med J. 2013;22(4):736–41.
Denas G et al. Antiphospholipid syndrome and the heart: a case series and literature review. Autoimmun Rev. 2015;14(3):214–22. A recent comprehensive review on antiphospholipid antibody syndrome.
Taraborelli M, Andreoli L, Tincani A. Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a ‘systemic disease’. Best Pract Res Clin Rheumatol. 2012;26(1):79–90.
Erdogan D et al. Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study. Stroke. 2005;36(3):592–6.
Lambova S. Cardiac manifestations in systemic sclerosis. World J Cardiol. 2014;6(9):993–1005.
Kahan A, Coghlan G, McLaughlin V. Cardiac complications of systemic sclerosis. Rheumatology (Oxford). 2009;48 Suppl 3:iii45–8.
Ciurzynski M et al. Assessment of left and right ventricular diastolic function in patients with systemic sclerosis. Kardiol Pol. 2008;66(3):269–76. discussion 277–8.
Heslinga SC et al. Diastolic left ventricular dysfunction in ankylosing spondylitis--a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(1):14–9.
Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Transl Med. 2015;3(4):51.
Caliskan M et al. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis. 2008;196(1):306–12.
Roldan CA et al. Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol. 1998;32(5):1397–404.
Turiel M et al. The role of echocardiographic techniques in connective tissue diseases. Autoimmun Rev. 2005;4(3):171–7.
Perez-Villa F et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study. Arthritis Rheum. 2005;53(3):460–7.
Ungprasert P et al. Cardiac involvement in mixed connective tissue disease: a systematic review. Int J Cardiol. 2014;171(3):326–30.
Sen D, Gonzalez-Mayda M, Brasington Jr RD. Cardiovascular disease in rheumatoid arthritis. Rheum Dis Clin North Am. 2014;40(1):27–49.
Corrao S et al. Rheumatoid arthritis affects left ventricular mass: systematic review and meta-analysis. Eur J Intern Med. 2015;26(4):259–67.
Myasoedova E et al. Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. Arthritis Rheum. 2013;65(7):1713–8.
Midtbo H et al. Disease activity and left ventricular structure in patients with rheumatoid arthritis. Rheumatology (Oxford). 2015;54(3):511–9.
Fatma E et al. Epicardial fat thickness in patients with rheumatoid arthritis. Afr Health Sci. 2015;15(2):489–95.
Toutouzas K et al. Myocardial ischaemia without obstructive coronary artery disease in rheumatoid arthritis: hypothesis-generating insights from a cross-sectional study. Rheumatology (Oxford). 2013;52(1):76–80.
Kakuta, K., et al., Chronic Inflammatory Disease Is an Independent Risk Factor for Coronary Flow Velocity Reserve Impairment Unrelated to the Processes of Coronary Artery Calcium Deposition. J Am Soc Echocardiogr, 2015. This recent paper described the prevalence of CMD in patients with rheumatologic diseases using stress Doppler echocardiography.
Saghir MK et al. Exercise echocardiography in rheumatoid arthritis: a case-control study. J Am Soc Echocardiogr. 2009;22(11):1228–31.
Kakuta K et al. Detection of coronary artery disease using coronary flow velocity reserve by transthoracic Doppler echocardiography versus multidetector computed tomography coronary angiography: influence of calcium score. J Am Soc Echocardiogr. 2014;27(7):775–85.
Rigo F et al. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol. 2003;91(3):269–73.
Turiel M et al. Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology (Oxford). 2009;48(7):834–9.
Vizzardi E et al. Echocardiographic evaluation of asymptomatic patients affected by rheumatoid arthritis. J Investig Med. 2012;60(8):1204–8.
Bhatia GS et al. Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden? J Am Coll Cardiol. 2006;47(6):1169–74.
Sitia S et al. Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiography. Int J Cardiol. 2012;160(1):8–14.
Fine NM et al. Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography. Ann Rheum Dis. 2014;73(10):1833–9.
Baktir AO et al. Preclinical impairment of myocardial function in rheumatoid arthritis patients. Detection of myocardial strain by speckle tracking echocardiography. Herz. 2015;40(4):669–74.
Ikonomidis I et al. Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra. Thromb Haemost. 2011;106(5):959–67.
Nicola PJ et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum. 2005;52(2):412–20.
Vizzardi, E., et al., Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors. Clin Exp Rheumatol, 2015.
Corrao S et al. Heart involvement in rheumatoid arthritis: systematic review and meta-analysis. Int J Cardiol. 2013;167(5):2031–8.
Anaya JM. Severe rheumatoid valvular heart disease. Clin Rheumatol. 2006;25(5):743–5.
Bourre-Tessier J et al. Features associated with cardiac abnormalities in systemic lupus erythematosus. Lupus. 2011;20(14):1518–25.
Leal, G.N., et al., Subclinical left ventricular dysfunction in childhood-onset systemic lupus erythematosus: a two-dimensional speckle-tracking echocardiographic study. Scand J Rheumatol, 2015: p. 1–8.
Foocharoen C et al. Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report). Rheumatology (Oxford). 2015;54(9):1616–21.
Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335(19):1424–30.
Roldan CA et al. Libman-Sacks endocarditis: detection, characterization, and clinical correlates by three-dimensional transesophageal echocardiography. J Am Soc Echocardiogr. 2015;28(7):770–9. This prospective study described the complementary value of 3D transesophageal echocardiography in the detection and characterization of Libman-Sacks endocarditis and the associated clinical manifestations.
Roldan CA. Diagnostic value of transesophageal echocardiography in Libman-Sacks endocarditis. Minerva Cardioangiol. 2009;57(4):467–81.
Hojnik M et al. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93(8):1579–87.
Roldan CA. Valvular disease associated with systemic illness. Cardiol Clin. 1998;16(3):531–50.
Maksimovic R et al. Cardiac imaging in rheumatic diseases. Rheumatology (Oxford). 2006;45 Suppl 4:iv26–31.
Cauduro SA et al. Clinical and echocardiographic characteristics of hemodynamically significant pericardial effusions in patients with systemic lupus erythematosus. Am J Cardiol. 2003;92(11):1370–2.
Roldan CA. Valvular and coronary heart disease in systemic inflammatory diseases: systemic disorders in heart disease. Heart. 2008;94(8):1089–101.
Hinchcliff M et al. Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol. 2012;30(2 Suppl 71):S30–7.
Khanna D et al. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum. 2013;65(12):3194–201. This systematic review provided recommendations for the screening and diagnosis of pulmonary hypertension in connective tissue disease.
Galie N et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119. These are the latest guidelines on the diagnosis and treatment of patients with pulmonary hypertension.
Chin K, Mathai SC. Exercise Echocardiography in Connective Tissue Disease. J Am Coll Cardiol. 2015;66(4):385–7.
Coghlan JG et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73(7):1340–9. This study proposed a novel, non-invasive evidence-based algorithm for the detection of pulmonary hypertension in systemic sclerosis.
Fukuda, Y., et al., Comprehensive Functional Assessment of Right-Sided Heart Using Speckle Tracking Strain for Patients with Pulmonary Hypertension. Echocardiography, 2016.
Kusunose K et al. Prediction of Future Overt Pulmonary Hypertension by 6-Min Walk Stress Echocardiography in Patients With Connective Tissue Disease. J Am Coll Cardiol. 2015;66(4):376–84. This paper described exercise testing using 6 minute walk test in predicting risk of developing pulmonary hypertension in patients with connective tissue disease.
Svealv BG et al. Prevalence of diastolic dysfunction in patients with ankylosing spondylitis: a cross-sectional study. Scand J Rheumatol. 2015;44(2):111–7.
Ustun N et al. Left ventricular systolic dysfunction in patients with ankylosing spondylitis without clinically overt cardiovascular disease by speckle tracking echocardiography. Rheumatol Int. 2015;35(4):607–11.
Park SH et al. Early cardiac valvular changes in ankylosing spondylitis: a transesophageal echocardiography study. J Cardiovasc Ultraso. 2012;20(1):30–6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Maha A. Al-Mohaissen and Kwan-Leung Chan declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Echocardiography
Rights and permissions
About this article
Cite this article
Al-Mohaissen, M.A., Chan, KL. Echocardiography in the Assessment of Patients with Rheumatologic Diseases. Curr Cardiol Rep 18, 72 (2016). https://doi.org/10.1007/s11886-016-0757-2
Published:
DOI: https://doi.org/10.1007/s11886-016-0757-2